Skip to main content

Table 2 Differences of NDO-LID antibodies according to their socioeconomic status and origin region

From: Social and environmental conditions related to Mycobacterium leprae infection in children and adolescents from three leprosy endemic regions of Colombia

Variable Sample size Anti-NDO-LID Anti-NDO-LID IgM Anti- NDO-LID IgG
N (%) protein A       
  (+) OR (95% CI) P-value (+) OR (95% CI) P-value (+) OR (95% CI) P-value
N (%) N (%) N (%)
SEC Low-low 42 (51) 15 (36) 10.55 (2.2–52.5) 0.001 18 (43) 6.75 (2–22.4) 0.001 5 (12) 5.3 (0.59–47.2) 0.102
SEC Low or Medium-low 40 (49) 2 (5)    4 (10)    1 (3)   
Origin UAChR 18 (22) 12 (67) 3.9 (1.9–8.1) UAChR vs AR < 0.0001 15 (83) 7.5 (1.98–28.3) UAChR vs AR < 0.0001 3 (6) 2.5 (1.6–3.7) UAChR vs AR 0.136
Origin CR 43 (52) 4 (9)    3 (7)    3 (7)   
Origin AR 21 (26) 1 (5) 5.6 (2.5–12.4) UAChR vs CR   4 (19) 11.9 (3.9–36.2) UAChR vs CR   0 1.8 (0.7–4.5) UAChR vs CR  
  1. OR odds ratio, CI confidence interval, (+) positive for the presence of anti-NDO-LID antibodies, SEC socioeconomic status, UAChR Uraba-Antioquia-Choco shared region, CR Caribbean region, AR Andean region, OR odds ratio, CI confidence interval, (+) positive for the presence of anti-NDO-LID antibodies